KCNK15 and pancreatic neoplasm: He et al. indicated that ALKBH5 was downregulated in pancreatic cancer with elevated m6A level and decreased expression of KCNK15-AS1, leading to enhanced migration and invasion of pancreatic tumor cells (He et al., 2018a).